Trial intelligence / Profile preview

PACE: Post-hospitalization Interventions for Physical Function

NCT02203656Phase 1Completed

Sponsor
The University of Texas Medical Branch at Galveston
Start
Oct 2013
Primary completion
Jul 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, single-blind trial of testosterone in Sarcopenia (5 arms), sponsored by The University of Texas Medical Branch at Galveston. Primary endpoint: Short Physical Performance Battery at 4 weeks. Started Oct 2013; status: completed.

02

Drugs

testosterone
03

Conditions

Sarcopenia

Beyond the preview

Go deeper on NCT02203656.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02203656.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call